Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
33.97
-2.60 (-7.11%)
May 21, 2025, 4:00 PM - Market closed
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $4.38 billion as of May 21, 2025. Its market cap has decreased by -39.32% in one year.
Market Cap
4.38B
Enterprise Value
2.80B
1-Year Change
-39.32%
Ranking
Category
Stock Price
$33.97
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $4.38B, an increase of 217.56%. That is a compound annual growth rate of 26.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2025 | 4.38B | -57.05% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | 1.35B | -1.90% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.89B |
| Johnson & Johnson | 366.90B |
| AbbVie | 328.04B |
| Novo Nordisk | 293.82B |
| UnitedHealth Group | 286.56B |
| Abbott Laboratories | 235.83B |
| Novartis AG | 215.48B |
| AstraZeneca | 214.95B |